UMBRELLA_IHI

?? Exciting news in stroke care! ??This week, we celebrate the launch of UMBRELLA_IHI, an ambitious initiative aimed at transforming stroke diagnosis, prevention, and treatment across Europe. Led by Vall d’Hebron Institute of Research (VHIR) - Vall d'Hebron Institut de Recerca and Siemens Healthineers, the project unites over 20 partners to bring cutting-edge AI-powered solutions to stroke patients, becoming a game changer for stroke care in Europe. ?? With more than 1 million stroke patients annually and nearly 10 million survivors in Europe, UMBRELLA’s innovative solutions will enhance diagnosis, speed up treatment, and reduce long-term complications, while improving the quality of life for those affected. The project is funded by the Innovative Health Initiative (IHI) and has an overall budget of €26.9 million. ?? Join us on this journey to advance stroke care and improve the lives of millions of stroke patients across Europe! ?? Learn more about how UMBRELLA is revolutionising stroke care by visiting our website: [https://loom.ly/FANsGnA] #StrokeCare?#AIInnovation?#HealthcareRevolution?#DigitalHealth?#StrokeSurvivors?#RealWorldData?#HealthTech?#UMBRELLAProject?#StrokeAwareness Innovative Health Initiative (IHI) Vall d’Hebron Institute of Research (VHIR) - Vall d'Hebron Institut de Recerca, Siemens Healthineers, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Teamit , Amsterdam UMC, Erasmus MC, Universit?tsklinikum Hamburg Eppendorf, KU Leuven, CERN, Nora Health, Stroke Alliance For Europe (SAFE), EATRIS, Bellvitge Biomedical Research Institute - IDIBELL, Instituto Pedro Nunes, EURECAT, Nacar Design, TrianecT, Nicolab, Allm EMEA, University of Basel, AstraZeneca, Philips, The Janssen Pharmaceutical Companies of Johnson & Johnson-Neuravi, Actelion (now Janssen Pulmonary Hypertension), Penumbra, Inc. Daiichi Sankyo Klelia Salpea

?? #BrainAwarenessWeek has been an opportunity to highlight the key challenges in stroke care—and the innovative solutions driving progress in prevention, early diagnosis, faster treatment, and long-term recovery. A major challenge remains: the limited understanding of all stroke causes—a critical barrier to improving outcomes. ?? ?? At Umbrella, we are committed to advancing research and innovation to bridge this gap. Watch the video to learn how we are tackling this challenge. Follow us as we reshape the future of stroke care in Europe!?? #StrokePrevention #StrokeCare #InnovationInHealth Innovative Health Initiative (IHI) Stroke Alliance For Europe (SAFE)

?? #BrainAwarenessWeek At UMBRELLA, we are working alongside our partners at Stroke Alliance For Europe (SAFE) to address critical challenges in stroke care. Our mission is clear: to transform stroke care across Europe through innovation and collaboration. ?? ?? One of the first key issues we are tackling is unequal access to treatment. Factors such as variability in #HealthcareInfrastructure, differences in national #StrokeProtocols, limited access to medicines and procedures, and disparities in rehabilitation services contribute to inconsistent patient outcomes across Europe. ?? Learn how #UMBRELLA is taking an innovative approach to bridging this gap. Join us on our journey to revolutionise stroke care across Europe!?? #BrainHealth #StrokeAwareness #InnovationInHealthcare

?? #BrainAwarenessWeek ?? Personalised stroke treatment remains a significant challenge in healthcare. At UMBRELLA, we’re on a mission to change that—bringing innovation to stroke care across Europe. ?? ?? Our approach is redefining how #stroke is treated, ensuring that patients receive the personalised care they need. ?? Watch our video to learn how we’re tackling this challenge! Let’s revolutionise stroke care in Europe together – follow us for updates! ???? #BrainAwarenessWeek! ???? #StrokeAwareness Stroke Alliance For Europe (SAFE)

???? It’s #BrainAwarenessWeek! ???? What does this mean? For one week each year, researchers and the global community shine a spotlight on the incredible progress in brain research—driving awareness, innovation, and advancements in brain health. ?? In collaboration with our partners at Stroke Alliance For Europe (SAFE), UMBRELLA will highlight how we are addressing critical challenges in #StrokeCare. As we embark on this ambitious project, our goal is to transform stroke care across Europe. ?? ?? The first key issue: Delayed diagnosis. Timely diagnosis is crucial in stroke care, yet too many people experience life-altering delays. Watch our video to discover how UMBRELLA is tackling this challenge with an innovative approach. Be part of the movement to transform stroke care across Europe – follow our journey! ?? #BrainHealth #StrokeAwareness

?? Brain Awareness Week kicks off next week! ???? ?? At Umbrella, we are thrilled to join Brain Awareness Week for the first time, with our partner Stroke Alliance For Europe (SAFE). This global initiative shines a spotlight on the incredible progress and benefits of brain research, driving awareness and innovation in brain health. ?? With our commitment to transforming stroke care across Europe, we will be sharing key insights into the challenges in stroke management and unveiling our innovative approach to #strokeprevention, early diagnosis, faster treatment, and reducing long-term impact. ?? ?? Stay tuned next week as we dive into these critical topics and join the global movement to advance brain health! Let’s make a difference together. ?? #BrainAwarenessWeek #StrokeCare #UmbrellaProject Innovative Health Initiative (IHI)

?? 1 in 4 people will suffer a stroke in their lifetime. When it comes to treatment, every second counts—because time is brain ?? During a press meeting at the European Society of Radiology in Vienna, Austria, a line-up of speakers, partners of UMBRELLA, shared their perspectives on technology and patient pathways with the attending journalists. ?? Prof. Robin Lemmens (KU Leuven), explained how a #FederatedLearning approach can transform stroke care by leveraging data in a secure and decentralised way. ?? Michael Scheuering, PhD (Siemens Healthineers) highlighted mobile stroke units and an "angio-only" approach— #innovations that can cut crucial minutes from treatment timelines. ?? The key takeaway? Collaboration and innovation is essential in driving progress and ensuring patients receive the best care—faster. Through the #UMBRELLAproject, we are paving the way for a smarter, more connected #strokecare system across Europe. ?? Join the conversation and help us make a difference in stroke care! #ECR2025 #HealthcareInnovation

Every year, over 1 million people in Europe suffer a stroke, and nearly 10 million live with its long-term impacts. Stroke is a leading cause of adult disability and accounts for approximately 460,000 deaths annually. ?? ?? Funded with €27 million by the Innovative Health Initiative (IHI) and industry partners, the #UMBRELLAproject aims to revolutionise these statistics by: ? Leveraging AI and digital tools for faster diagnosis and improved treatment decisions. ? Standardising protocols to enhance outcomes, even in underserved areas. ? Advancing prevention by addressing strokes with unknown causes. Co-led by Vall d’Hebron Institute of Research (VHIR) - Vall d'Hebron Institut de Recerca and Siemens Healthineers, #UMBRELLA unites experts from hospitals, academia, and industry to save lives, reduce disability, and enhance quality of life for stroke patients across Europe. ?? Follow us and subscribe to our newsletter to discover how we're revolutionising stroke care. ?? Learn more on our website: https://loom.ly/-mC2PpI #StrokeCare #HealthcareInnovation #AIHealth #UMBRELLAProject EATRIS, Erasmus MC, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, EURECAT, KU Leuven, CERN, Amsterdam UMC, Universit?tsklinikum Hamburg Eppendorf, University of Basel, Universit?tsspital Basel (USB), Stroke Alliance For Europe (SAFE), Actelion Pharmaceuticals Deutschland GmbH, Daiichi Sankyo Espa?a, AstraZeneca, The Janssen Pharmaceutical Companies of Johnson & Johnson, Penumbra, Inc., Philips, Nicolab, NoraHealth, Teamit , TrianecT, Allm EMEA, Nacar Design, Bellvitge Biomedical Research Institute - IDIBELL, Instituto Pedro Nunes, Neuravi.

Exciting news! ?? UMBRELLA takes the stage?as Peter Schardt, Arlene Wilkie, and Carlos Molina speak at HLTH Europe, exploring the Umbrella Project and the transformative impact of #AI on stroke care. ?? Join us on this journey—follow us for all the latest updates! ?? #HLTHEurope #AIinHealthcare #Innovation #StrokeCare #HealthTech

?? The Power of Partnership: UMBRELLA’s Collective Impact ?? The UMBRELLA Project is more than just a vision—it’s a collaboration of over 20 leading public and private organisations, uniting expertise to transform stroke care across Europe. ?? Our Partners: ? Public institutions, including pioneering research centres and universities ? Patient representatives ? Industry leaders ? SMEs and startups ? Third-party organisations ?? Co-Led by: Vall d’Hebron Institute of Research (VHIR) - Vall d'Hebron Institut de Recerca and Siemens Healthineers. ?? Together, we are driving innovation in stroke prevention, diagnosis, and treatment. To learn more about all our partners, visit our website! ?? Follow us to see how partnerships are shaping the future of healthcare! #StrokeCare #HealthcareInnovation #AIHealth #UMBRELLAProject #IHI EATRIS, Erasmus MC, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, EURECAT, KU Leuven, CERN, Amsterdam UMC, Universit?tsklinikum Hamburg Eppendorf, University of Basel, Universit?tsspital Basel (USB), Stroke Alliance For Europe (SAFE), Actelion Pharmaceuticals Deutschland GmbH, Daiichi Sankyo Espa?a, AstraZeneca, The Janssen Pharmaceutical Companies of Johnson & Johnson, Penumbra, Inc., Philips, Nicolab, NoraHealth, Teamit , TrianecT, Allm EMEA, Nacar Design, Bellvitge Biomedical Research Institute - IDIBELL, Instituto Pedro Nunes, Neuravi.